| A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity AT Huang, B Garcia-Carreras, MDT Hitchings, B Yang, LC Katzelnick, ... Nature communications 11 (1), 4704, 2020 | 1044 | 2020 |
| Antibody-dependent enhancement of severe dengue disease in humans LC Katzelnick, L Gresh, ME Halloran, JC Mercado, G Kuan, A Gordon, ... Science 358 (6365), 929-932, 2017 | 977 | 2017 |
| Global spread of dengue virus types: mapping the 70 year history JP Messina, OJ Brady, TW Scott, C Zou, DM Pigott, KA Duda, S Bhatt, ... Trends in microbiology 22 (3), 138-146, 2014 | 822 | 2014 |
| Antibody landscapes after influenza virus infection or vaccination JM Fonville, SH Wilks, SL James, A Fox, M Ventresca, M Aban, L Xue, ... Science 346 (6212), 996-1000, 2014 | 437 | 2014 |
| The potential for respiratory droplet–transmissible A/H5N1 influenza virus to evolve in a mammalian host CA Russell, JM Fonville, AEX Brown, DF Burke, DL Smith, SL James, ... Science 336 (6088), 1541-1547, 2012 | 397 | 2012 |
| Dengue viruses cluster antigenically but not as discrete serotypes LC Katzelnick, JM Fonville, GD Gromowski, JB Arriaga, A Green, ... Science 349 (6254), 1338-1343, 2015 | 230 | 2015 |
| Reconstruction of antibody dynamics and infection histories to evaluate dengue risk H Salje, DAT Cummings, I Rodriguez-Barraquer, LC Katzelnick, J Lessler, ... Nature 557 (7707), 719-723, 2018 | 225 | 2018 |
| Zika virus infection enhances future risk of severe dengue disease LC Katzelnick, C Narvaez, S Arguello, B Lopez Mercado, D Collado, ... Science 369 (6507), 1123-1128, 2020 | 216 | 2020 |
| Dengue: knowledge gaps, unmet needs, and research priorities LC Katzelnick, J Coloma, E Harris The Lancet Infectious Diseases 17 (3), e88-e100, 2017 | 210 | 2017 |
| Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort LC Katzelnick, M Montoya, L Gresh, A Balmaseda, E Harris Proceedings of the National Academy of Sciences 113 (3), 728-733, 2016 | 178 | 2016 |
| Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua A Gordon, L Gresh, S Ojeda, LC Katzelnick, N Sanchez, JC Mercado, ... PLoS medicine 16 (1), e1002726, 2019 | 163 | 2019 |
| Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas M Montoya, M Collins, W Dejnirattisai, LC Katzelnick, H Puerta-Guardo, ... The Journal of infectious diseases 218 (4), 536-545, 2018 | 155 | 2018 |
| Immune correlates of protection for dengue: state of the art and research agenda LC Katzelnick, E Harris, R Baric, BA Coller, J Coloma, JE Crowe Jr, ... Vaccine 35 (36), 4659-4669, 2017 | 87 | 2017 |
| Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus LC Katzelnick, A Coello Escoto, BD McElvany, C Chávez, H Salje, W Luo, ... PLoS neglected tropical diseases 12 (10), e0006862, 2018 | 85 | 2018 |
| COVID-19 vaccines: should we fear ADE? SB Halstead, L Katzelnick The Journal of infectious diseases 222 (12), 1946-1950, 2020 | 83 | 2020 |
| SARS-CoV-2 BA. 1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies S Lusvarghi, SD Pollett, SN Neerukonda, W Wang, R Wang, R Vassell, ... Science Translational Medicine 14 (645), eabn8543, 2022 | 78 | 2022 |
| Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort KS Corbett, L Katzelnick, H Tissera, A Amerasinghe, AD De Silva, ... The Journal of infectious diseases 211 (4), 590-599, 2015 | 75 | 2015 |
| Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines KS Vannice, A Wilder-Smith, ADT Barrett, K Carrijo, M Cavaleri, A de Silva, ... Vaccine 36 (24), 3411-3417, 2018 | 69 | 2018 |
| Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika P Andrade, C Gimblet-Ochieng, F Modirian, M Collins, M Cárdenas, ... Nature communications 10 (1), 938, 2019 | 66 | 2019 |
| Impacts of Zika emergence in Latin America on endemic dengue transmission RK Borchering, AT Huang, L Mier-y-Teran-Romero, DP Rojas, ... Nature communications 10 (1), 5730, 2019 | 60 | 2019 |
